Armata Pharmaceuticals, Inc. SEC filings ARMP

Armata Pharmaceuticals, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jan 27, 2004. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 23, 2026 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 27, 2026 Dec 31, 2025
10-K Annual report Mar 25, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 28, 2025 Dec 31, 2024
10-K Annual report Mar 21, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 29, 2024 Dec 31, 2023
10-K Annual report Mar 21, 2024 Dec 31, 2023
ARS Annual report to shareholders Aug 3, 2023 Dec 31, 2022
10-K Annual report Mar 16, 2023 Dec 31, 2022
10-K Annual report Mar 17, 2022 Dec 31, 2021
10-K Annual report Mar 18, 2021 Dec 31, 2020
10-K Annual report Mar 19, 2020 Dec 31, 2019
10-K Annual report Mar 25, 2019 Dec 31, 2018
10-K Annual report Mar 14, 2018 Dec 31, 2017
10-K Annual report Mar 27, 2017 Dec 31, 2016
10-K Annual report Mar 30, 2016 Dec 31, 2015
10-K/A Amended annual report Apr 30, 2015 Dec 31, 2014
10-K Annual report Apr 15, 2015 Dec 31, 2014
10-K/A Amended annual report Apr 15, 2015 Dec 31, 2013
10-K/A Amended annual report Sep 12, 2014 Dec 31, 2013
10-K/A Amended annual report May 23, 2014 Dec 31, 2013
10-K Annual report Apr 15, 2014 Dec 31, 2013
10-K Annual report Mar 31, 2009 Dec 31, 2008
10-K Annual report Mar 25, 2008 Dec 31, 2007
ARS Annual report to shareholders Apr 17, 2007 Dec 31, 2006
10-K Annual report Mar 29, 2007 Dec 31, 2006
ARS Annual report to shareholders Apr 19, 2006 Dec 31, 2005
10-K Annual report Mar 16, 2006 Dec 31, 2005
ARS Annual report to shareholders Apr 20, 2005 Dec 31, 2004
10-K Annual report Mar 4, 2005 Dec 31, 2004
ARS Annual report to shareholders Apr 9, 2004 Dec 31, 2003
10-K Annual report Mar 12, 2004 Dec 31, 2003

Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
ARMP (NYSE)
Fiscal year ends
December 31
Incorporated in
WA
Headquarters
Los Angeles, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
921114
Former names
AmpliPhi Biosciences Corp (until May 8, 2019); TARGETED GENETICS CORP /WA/ (until Feb 11, 2011)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.